Atorvastatin inhibits CXCR7 induction to reduce macrophage migration

Biochemical Pharmacology

Volumn 89, Issue 1, 2014, Pages 99-108

  Ma, Wanshu ^a   Liu, Yiwei ^a   Wang, Chuan ^a   Zhang, Lingxin ^a   Crocker, Laura ^a   Shen, Jianzhong ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Atorvastatin; Cell migration; Chemokine receptor; CXCR7; Macrophages

Indexed keywords

ATORVASTATIN; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; COMPACTIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MESSENGER RNA; MEVALONIC ACID; PRAVASTATIN; RHO KINASE INHIBITOR; SIMVASTATIN; SQUALENE SYNTHASE;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL STRUCTURE; CELL VIABILITY; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PRENYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMD3100 (PUBCHEM CID: 65015); ATORVASTATIN; ATORVASTATIN (PUBCHEM CID: 15378998); CELL MIGRATION; CHEMOKINE RECEPTOR; CXCR7; FLUVASTATIN (PUBCHEM CID: 446155); MACROPHAGES; MEVALONATE (PUBCHEM CID: 5288798); MEVASTATIN (PUBCHEM CID: 16760562); PRAVASTATIN (PUBCHEM CID: 16759173); SIMVASTATIN (PUBCHEM CID: 54454); SQUALESTATIN (PUBCHEM CID: 6438355); Y-27632 (PUBCHEM CID: 9901617);

ANTICHOLESTEREMIC AGENTS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CHOLESTEROL; DNA PRIMERS; HEPTANOIC ACIDS; HUMANS; MACROPHAGES; PYRROLES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR; RNA, MESSENGER;

EID: 84898017437     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.02.014     Document Type: Article

References (33)

1. M. Ii, and D.W. Losordo Statins and the endothelium Vascular Pharmacology 46 2007 1 9 (Pubitemid 44856372)
2. J.K. Liao, and U. Laufs Pleiotropic effects of statins Annual Review of Pharmacology and Toxicology 45 2005 89 118 (Pubitemid 40261799)
3. K.H. Han, J. Ryu, K.H. Hong, J. Ko, Y.K. Pak, and J.B. Kim et al. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo Circulation 111 2005 1439 1447 (Pubitemid 40396811)
4. K.J. Woollard, and F. Geissmann Monocytes in atherosclerosis: subsets and functions Nature Reviews Cardiology 7 2010 77 86
5. Z. Chi, and A.J. Melendez Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis Cell Adhesion & Migration 1 2007 171 175
6. W. Ma, Y. Liu, N. Ellison, and J. Shen Induction of C-X-C chemokine receptor type 7 (CXCR7) switches stromal cell-derived factor-1 (SDF-1) signaling and phagocytic activity in macrophages linked to atherosclerosis Journal of Biological Chemistry 288 2013 15481 15494
7. E.A. Higuita, F.A. Jaimes, M.T. Rugeles, and C.J. Montoya In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4 AIDS Research and Therapy 10 2013 10
8. M. Masori A.J, and Y. Nakaya Disruption of stromal-derived factor-1/chemokine receptor 4 by simvastatin Iranian Cardiovascular Research Journal 2010 4
9. L. Ding, W. Ma, T. Littmann, R. Camp, and J. Shen The P2Y(2) nucleotide receptor mediates tissue factor expression in human coronary artery endothelial cells Journal of Biological Chemistry 286 2011 27027 27038
10. J. Shen, S.P. Halenda, M. Sturek, and P.A. Wilden Cell-signaling evidence for adenosine stimulation of coronary smooth muscle proliferation via the A1 adenosine receptor Circulation Research 97 2005 574 582 (Pubitemid 41361748)
11. J. Shen, U.M. Chandrasekharan, M.Z. Ashraf, E. Long, R.E. Morton, and Y. Liu et al. Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis Circulation Research 106 2010 902 910
12. S. Al-Nasiry, N. Geusens, M. Hanssens, C. Luyten, and R. Pijnenborg The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells Human Reproduction 22 2007 1304 1309 (Pubitemid 47062799)
13. J. Shen, and P.E. DiCorleto ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways Circulation Research 102 2008 448 456 (Pubitemid 351651109)
14. L. Hernandez, M.A. Magalhaes, S.J. Coniglio, J.S. Condeelis, and J.E. Segall Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis Breast Cancer Research 13 2011 R128
15. T.T. Tuomisto Gene expression in macrophage-rich inflammatory cell infiltrates in human atherosclerotic lesions as studied by laser microdissection and DNA array: overexpression of HMG-CoA reductase, colony stimulating factor receptors, CD11A/CD18 integrins, and interleukin receptors Arteriosclerosis, Thrombosis, and Vascular Biology 23 2003 2235 2240 (Pubitemid 37532326)
16. M. Puato, E. Faggin, M. Rattazzi, A. Zambon, F. Cipollone, and F. Grego et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy Stroke 41 2010 1163 1168
17. R. Qiu, A. Cai, Y. Dong, Y. Zhou, D. Yu, and Y. Huang et al. SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects Journal of Biomedical Science 19 2012 99
18. M.A. Zhukovsky, P.H. Lee, A. Ott, and V. Helms Putative cholesterol-binding sites in human immunodeficiency virus (HIV) coreceptors CXCR4 and CCR5 Proteins 81 2013 555 567
19. A. Hilgendorff, H. Muth, B. Parviz, A. Staubitz, W. Haberbosch, and H. Tillmanns et al. Statins differ in their ability to block NF-kappaB activation in human blood monocytes International Journal of Clinical Pharmacology and Therapeutics 41 2003 397 401 (Pubitemid 37138482)
20. J.L. Martin-Ventura, L.M. Blanco-Colio, A. Gomez-Hernandez, B. Munoz-Garcia, M. Vega, and J. Serrano et al. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month Stroke 36 2005 1796 1800 (Pubitemid 41098781)
21. M. Crisby, G. Nordin-Fredriksson, P.K. Shah, J. Yano, J. Zhu, and J. Nilsson Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization Circulation 103 2001 926 933 (Pubitemid 32183796)
22. L. Sánchez-Martín, P. Sánchez-Mateos, and C. Cabañas CXCR7 impact on CXCL12 biology and disease Trends in Molecular Medicine 19 2013 12 22
23. J.M. Burns A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development Journal of Experimental Medicine 203 2006 2201 2213 (Pubitemid 44352240)
24. B. Boldajipour, H. Mahabaleshwar, E. Kardash, M. Reichman-Fried, H. Blaser, and S. Minina et al. Control of chemokine-guided cell migration by ligand sequestration Cell 132 2008 463 473 (Pubitemid 351191997)
25. T.N. Hartmann, V. Grabovsky, R. Pasvolsky, Z. Shulman, E.C. Buss, and A. Spiegel et al. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells Journal of Leukocyte Biology 84 2008 1130 1140
26. E. Lee, J. Han, K. Kim, H. Choi, E.G. Cho, and T.R. Lee CXCR7 mediates SDF1-induced melanocyte migration Pigment Cell & Melanoma Research 26 2013 58 66
27. B.A. Zabel, Y. Wang, S. Lewen, R.D. Berahovich, M.E. Penfold, and P. Zhang et al. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands Journal of Immunology 183 2009 3204 3211
28. Z. Miao, K.E. Luker, B.C. Summers, R. Berahovich, M.S. Bhojani, and A. Rehemtulla et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature Proceedings of the National Academy of Sciences of the United States of America 104 2007 15735 15740 (Pubitemid 350035369)
29. B. Mazzinghi, E. Ronconi, E. Lazzeri, C. Sagrinati, L. Ballerini, and M.L. Angelotti et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells The Journal of Experimental Medicine 205 2008 479 490 (Pubitemid 351281611)
30. M. Esencay, Y. Sarfraz, and D. Zagzag CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1alpha BMC Cancer 13 2013 347
31. C. Dambly-Chaudiere, N. Cubedo, and A. Ghysen Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1 BMC Developmental Biology 7 2007 23
32. Y. Wang, G. Li, A. Stanco, J.E. Long, D. Crawford, and G.B. Potter et al. CXCR4 and CXCR7 have distinct functions in regulating interneuron migration Neuron 69 2011 61 76
33. J.P. Perchellet, E.M. Perchellet, K.R. Crow, K.R. Buszek, N. Brown, and S. Ellappan et al. Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl- coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins International Journal of Molecular Medicine 24 2009 633 643